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Background
Tyrosinase (EC 1.14.18.1) is a copper-containing oxidase
that is widely distributed in mammals, invertebrates,
plants and microorganisms. In mammals the enzyme is
essential for the formation of melanin pigments, whereas
tyrosinases in fruit and vegetables are related to the
browning reaction that occurs upon bruising and long
term storage. Tyrosinase is of great interest for many appli-
cations in the field of medicine, biotechnology and food
engineering. It is a promising target enzyme for prodrug
activations in melanomas and in biotechnological appli-
cations including crosslinking of protein matrices. It is of
great importance to find ligands and inhibitors for tyrosi-
nase. Structural studies and screening for ligands and
inhibitors can be carried out using NMR spectroscopy
with isotopically labeled tyrosinase. Therefore, we cloned
a novel tyrosinase from Trichoderma reesei and expressed it
heterologously in the methylotrophic yeast Pichia pastoris.
Results
A novel tyrosinase, tyrosinase 2 (TYR2), was cloned from
Trichoderma reesei. The cDNA sequence was expressed
under the control of the AOX1 promoter in the Pichia pas-
toris X-33 strain. The Saccharomyces cerevisiae α-MF prepro
sequence was used for secretion and an N-terminal His6-
tag was fused to the tyrosinase to facilitate the detection
and purification of the recombinant protein. Heterolo-
gous expression was carried out in shake flask cultivations
and the enzymatic activity was measured directly on the
culture medium, using L-Dopa as a substrate. A protein of
approximately 45 kDa was detected by Western blot with
antibodies against the His-tag. The full length of TYR2 has
a predicted MW of 60.4 kDa. When TYR2 is homolo-
gously over-expressed in Trichoderma reesei, the C-terminal
is cleaved and the mature protein has a MW of 43.5 kDa.
Thus, it seems probable that Pichia pastoris processes the
C-terminal correctly. Extensive optimisation of the expres-
sion in shake flasks was carried out as the stable isotope
labels are costly. Different temperatures, different CuSO4
and NH4SO4 concentrations and different shake flasks
were tested. The expression level of recombinant TYR2
was increased tenfold as a result of the optimisation. Met-
abolic 15N-labeling of TYR2 was carried out with
15NH4SO4 in minimal medium to assess its suitability for
investigations by NMR spectroscopy. Initial 3D heteronu-
clear 1H-15N HSQC NMR spectrum of TYR2 showed sig-
nals with chemical shifts typical of folded proteins.
Conclusion
The Trichoderma reesei tyrosinase 2 was successfully
expressed and uniformly 15N-labeled in the yeast Pichia
pastoris. This methylotrophic yeast is a suitable expression
system for the production of recombinant proteins for
NMR studies as it is cost-effective and possesses the ability
to perform many of the posttranslational modifications of
higher eukaryotes.
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